Skip to main content
. 2021 May 14;238(7):1857–1866. doi: 10.1007/s00213-021-05814-x

Fig. 1.

Fig. 1

The study design timeline is shown illustrating the two periods of tradipitant dosing in this crossover study (0 or 85 mg/bid) and the timing of all experimental test sessions